Literature DB >> 16263886

Limitations on physical performance and daily activities among long-term survivors of childhood cancer.

Kirsten K Ness1, Ann C Mertens, Melissa M Hudson, Melanie M Wall, Wendy M Leisenring, Kevin C Oeffinger, Charles A Sklar, Leslie L Robison, James G Gurney.   

Abstract

BACKGROUND: Survivors of childhood cancer may experience important disease- and treatment-related late effects, including functional limitations.
OBJECTIVE: This study evaluated performance limitations and restricted abilities to participate in personal care, to engage in routine activities like shopping or housework, and to attend work or school (participation restrictions) in a cohort of survivors of childhood cancer.
SETTING: Epidemiologic survey and 26 institutions that treat childhood cancer. PATIENTS: Participants included 11 481 persons who were treated for primary brain cancer, leukemia, Hodgkin disease, non-Hodgkin lymphoma, kidney tumor, neuroblastoma, soft-tissue sarcoma, or malignant bone tumor before the age of 21 years and who survived at least 5 years after diagnosis. The comparison group included 3839 siblings of survivors of childhood cancer. MEASUREMENT: Medical data were abstracted, and participants or parents (if the participants were <18 years of age at survey completion) completed a 24-page questionnaire.
RESULTS: Compared with siblings, survivors were more likely to report performance limitations (risk ratio, 1.8 [95% CI, 1.7 to 2.0]) and to report restricted participation in personal care skills (risk ratio, 4.7 [CI, 3.0 to 7.2]), routine activities (risk ratio, 4.7 [CI, 3.6 to 6.2]), and the ability to attend work or school (risk ratio, 5.9 [CI, 4.5 to 7.6]). Survivors of brain (26.6%) and bone (36.9%) cancer were most likely to report performance limitations, restricted ability to do routine activities (20.9% and 8.5%, respectively), and restricted ability to attend work or school (20.0% and 11.2%, respectively). Survivors of brain cancer were also most likely to report restricted abilities to perform personal care (10.5%). LIMITATIONS: There was the potential for participants to be healthier or more physically capable than nonparticipants or for persons to be more motivated to participate in this study if they had functional deficits. In addition, the nature of the questionnaire did not allow specific physical limitations to be measured.
CONCLUSION: Long-term survivors of childhood cancer are at increased risk for functional limitations in physical performance and in participation in activities needed for daily living.

Entities:  

Mesh:

Year:  2005        PMID: 16263886     DOI: 10.7326/0003-4819-143-9-200511010-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   51.598


  93 in total

1.  Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life.

Authors:  Michele Montgomery; Sujuan Huang; Cheryl L Cox; Wendy M Leisenring; Kevin C Oeffinger; Melissa M Hudson; Jill Ginsberg; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2010-10-05       Impact factor: 4.442

2.  Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory ™ generic core scales, cancer module, and multidimensional fatigue scale in long-term adult survivors of pediatric cancer.

Authors:  Rhonda S Robert; Raheem J Paxton; Shana L Palla; Grace Yang; Martha A Askins; Shaini E Joy; Joann L Ater
Journal:  Pediatr Blood Cancer       Date:  2012-02-02       Impact factor: 3.167

Review 3.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

Review 4.  Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients.

Authors:  Dina Randazzo; Katherine B Peters
Journal:  CNS Oncol       Date:  2016-07-11

5.  Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status.

Authors:  Kimberly P Raghubar; Jessica Orobio; M Douglas Ris; Andrew M Heitzer; Alexandra Roth; Austin L Brown; M Fatih Okcu; Murali Chintagumpala; David R Grosshans; Arnold C Paulino; Anita Mahajan; Lisa S Kahalley
Journal:  Pediatr Blood Cancer       Date:  2019-05-27       Impact factor: 3.167

6.  Factors affecting outcomes in patients treated surgically for upper extremity tumors and tumor-like lesions.

Authors:  Jesse E Otero; Christopher M Graves; Ashley TeKippe; Joseph A Buckwalter; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2013

Review 7.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

Review 8.  Physical performance limitations in the Childhood Cancer Survivor Study cohort.

Authors:  Kirsten K Ness; Melissa M Hudson; Jill P Ginsberg; Rajaram Nagarajan; Sue C Kaste; Neyssa Marina; John Whitton; Leslie L Robison; James G Gurney
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.

Authors:  Neyssa Marina; Melissa M Hudson; Kendra E Jones; Daniel A Mulrooney; Raffi Avedian; Sarah S Donaldson; Rita Popat; Dee W West; Paul Fisher; Wendy Leisenring; Marilyn Stovall; Leslie L Robison; Kirsten K Ness
Journal:  Arch Phys Med Rehabil       Date:  2013-02-01       Impact factor: 3.966

10.  Development of the perceived barriers scale: a new instrument identifying barriers to career development and employment for young adult survivors of pediatric CNS tumors.

Authors:  David R Strauser; Fong Chan; Elizabeth Fine; Kanako Iwanaga; Chelsea Greco; Cori Liptak
Journal:  J Cancer Surviv       Date:  2018-10-24       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.